VA SB1269 | 2021 | Regular Session

Note: Carry Foward to future SB1269

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Engrossed on January 28 2021 - 50% progression, died in chamber
Action: 2021-02-08 - Continued to Special Session 1 in Labor and Commerce by voice vote
Text: Latest bill text (Comm Sub) [HTML]

Summary

Health insurance; authorization of drug prescribed for the treatment of a mental disorder. Requires that any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, contain provisions that require, when a carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization can be required if (i) the drug is a covered benefit, (ii) the prescription does not exceed the U.S. Food and Drug Administration-labeled dosages, (iii) the prescription has been continuously issued for no fewer than three months, and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. The bill provides that this requirement does not prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription is issued. The bill also provides that such provider contracts contain provisions requiring a carrier to honor a prior authorization issued by the carrier for a drug regardless if the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued. Under the bill, provisions related to provider contracts and prior authorization will apply to the state insurance health plan. Health insurance; authorization of drug prescribed for the treatment of a mental disorder. Requires that any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, contain provisions that require, when a carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization can be required if (i) the drug is a covered benefit, (ii) the prescription does not exceed the U.S. Food and Drug Administration-labeled dosages, (iii) the prescription has been continuously issued for no fewer than three months, and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. The bill provides that this requirement does not prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription is issued. The bill also provides that such provider contracts contain provisions requiring a carrier to honor a prior authorization issued by the carrier for a drug regardless if the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued. Under the bill, provisions related to provider contracts and prior authorization will apply to the state insurance health plan.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health insurance; authorization of drug prescribed for the treatment of a mental disorder.

Sponsors


Roll Calls

2021-01-29 - Senate - Senate: Read third time and passed Senate (37-Y 0-N) (Y: 37 N: 0 NV: 0 Abs: 2) [PASS]
2021-01-27 - Senate - Senate: Constitutional reading dispensed (39-Y 0-N) (Y: 39 N: 0 NV: 0 Abs: 0) [PASS]
2021-01-25 - Senate - Senate: Reported from Commerce and Labor with substitute (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2021-02-08HouseContinued to Special Session 1 in Labor and Commerce by voice vote
2021-02-02HouseReferred to Committee on Labor and Commerce
2021-02-02HouseRead first time
2021-02-02HousePlaced on Calendar
2021-01-29SenateRead third time and passed Senate (37-Y 0-N)
2021-01-28SenateEngrossed by Senate - committee substitute SB1269S1
2021-01-28SenateCommittee substitute agreed to 21103534D-S1
2021-01-28SenateReading of substitute waived
2021-01-28SenateRead second time
2021-01-27SenateConstitutional reading dispensed (39-Y 0-N)
2021-01-25SenateCommittee substitute printed 21103534D-S1
2021-01-25SenateReported from Commerce and Labor with substitute (15-Y 0-N)
2021-01-12SenateReferred to Committee on Commerce and Labor
2021-01-12SenatePrefiled and ordered printed; offered 01/13/21 21101311D

Same As/Similar To

SB1269 (Carry Over) 2021-02-08 - Continued to Special Session 1 in Labor and Commerce by voice vote

Code Citations

ChapterArticleSectionCitation TypeStatute Text
3823407.15:2(n/a)See Bill Text

Virginia State Sources


Bill Comments

feedback